Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.

Identifieur interne : 000924 ( Ncbi/Merge ); précédent : 000923; suivant : 000925

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.

Auteurs : Sheng-Qun Deng [République populaire de Chine] ; Hong-Juan Peng [République populaire de Chine]

Source :

RBID : pubmed:32093211

Abstract

In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible.

DOI: 10.3390/jcm9020575
PubMed: 32093211

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32093211

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.</title>
<author>
<name sortKey="Deng, Sheng Qun" sort="Deng, Sheng Qun" uniqKey="Deng S" first="Sheng-Qun" last="Deng">Sheng-Qun Deng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515</wicri:regionArea>
<placeName>
<settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Peng, Hong Juan" sort="Peng, Hong Juan" uniqKey="Peng H" first="Hong-Juan" last="Peng">Hong-Juan Peng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515</wicri:regionArea>
<placeName>
<settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32093211</idno>
<idno type="pmid">32093211</idno>
<idno type="doi">10.3390/jcm9020575</idno>
<idno type="wicri:Area/PubMed/Corpus">000481</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000481</idno>
<idno type="wicri:Area/PubMed/Curation">000481</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000481</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000475</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000475</idno>
<idno type="wicri:Area/Ncbi/Merge">000924</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.</title>
<author>
<name sortKey="Deng, Sheng Qun" sort="Deng, Sheng Qun" uniqKey="Deng S" first="Sheng-Qun" last="Deng">Sheng-Qun Deng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515</wicri:regionArea>
<placeName>
<settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Peng, Hong Juan" sort="Peng, Hong Juan" uniqKey="Peng H" first="Hong-Juan" last="Peng">Hong-Juan Peng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515</wicri:regionArea>
<placeName>
<settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of clinical medicine</title>
<idno type="ISSN">2077-0383</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">32093211</PMID>
<DateRevised>
<Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">2077-0383</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2020</Year>
<Month>Feb</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Journal of clinical medicine</Title>
<ISOAbbreviation>J Clin Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E575</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm9020575</ELocationID>
<Abstract>
<AbstractText>In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Deng</LastName>
<ForeName>Sheng-Qun</ForeName>
<Initials>SQ</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Hong-Juan</ForeName>
<Initials>HJ</Initials>
<Identifier Source="ORCID">0000-0002-9345-8218</Identifier>
<AffiliationInfo>
<Affiliation>Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>81572012</GrantID>
<Agency>National Natural Science Foundation of China</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>81772217</GrantID>
<Agency>National Natural Science Foundation of China</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>20180907</GrantID>
<Agency>National Natural Science Foundation of China</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>81971954</GrantID>
<Agency>National Natural Science Foundation of China</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>2016A030311025</GrantID>
<Agency>Guangdong Provincial Natural Science Foundation Project</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>2017A030313694</GrantID>
<Agency>Guangdong Provincial Natural Science Foundation Project</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>2018A050506038</GrantID>
<Agency>Science and Technology Planning Project of Guangdong Province</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>201904020011</GrantID>
<Agency>Key project of Guangzhou science research</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>02</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>J Clin Med</MedlineTA>
<NlmUniqueID>101606588</NlmUniqueID>
<ISSNLinking>2077-0383</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">2019-nCoV</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">clinical characteristics</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">diagnosis</Keyword>
<Keyword MajorTopicYN="N">pneumonia</Keyword>
<Keyword MajorTopicYN="N">prevention and control</Keyword>
<Keyword MajorTopicYN="N">public health</Keyword>
<Keyword MajorTopicYN="N">treatment</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>01</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>02</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>02</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32093211</ArticleId>
<ArticleId IdType="pii">jcm9020575</ArticleId>
<ArticleId IdType="doi">10.3390/jcm9020575</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<region>
<li>Guangdong</li>
</region>
<settlement>
<li>Jiangmen</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<region name="Guangdong">
<name sortKey="Deng, Sheng Qun" sort="Deng, Sheng Qun" uniqKey="Deng S" first="Sheng-Qun" last="Deng">Sheng-Qun Deng</name>
</region>
<name sortKey="Peng, Hong Juan" sort="Peng, Hong Juan" uniqKey="Peng H" first="Hong-Juan" last="Peng">Hong-Juan Peng</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000924 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000924 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:32093211
   |texte=   Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:32093211" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021